These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
206 related items for PubMed ID: 6337710
1. Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma. Green SB, Byar DP, Walker MD, Pistenmaa DA, Alexander E, Batzdorf U, Brooks WH, Hunt WE, Mealey J, Odom GL, Paoletti P, Ransohoff J, Robertson JT, Selker RG, Shapiro WR, Smith KR, Wilson CB, Strike TA. Cancer Treat Rep; 1983 Feb; 67(2):121-32. PubMed ID: 6337710 [Abstract] [Full Text] [Related]
2. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. Walker MD, Green SB, Byar DP, Alexander E, Batzdorf U, Brooks WH, Hunt WE, MacCarty CS, Mahaley MS, Mealey J, Owens G, Ransohoff J, Robertson JT, Shapiro WR, Smith KR, Wilson CB, Strike TA. N Engl J Med; 1980 Dec 04; 303(23):1323-9. PubMed ID: 7001230 [Abstract] [Full Text] [Related]
3. Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001. Shapiro WR, Green SB, Burger PC, Mahaley MS, Selker RG, VanGilder JC, Robertson JT, Ransohoff J, Mealey J, Strike TA. J Neurosurg; 1989 Jul 04; 71(1):1-9. PubMed ID: 2661738 [Abstract] [Full Text] [Related]
4. Randomized comparisons of radiotherapy and carmustine versus procarbazine versus dacarbazine for the treatment of malignant gliomas following surgery: a Southwest Oncology Group Study. Eyre HJ, Eltringham JR, Gehan EA, Vogel FS, Al-Sarraf M, Talley RW, Costanzi JJ, Athens JW, Oishi N, Fletcher WS. Cancer Treat Rep; 1986 Sep 04; 70(9):1085-90. PubMed ID: 3017551 [Abstract] [Full Text] [Related]
5. The Brain Tumor Cooperative Group NIH Trial 87-01: a randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine. Selker RG, Shapiro WR, Burger P, Blackwood MS, Arena VC, Gilder JC, Malkin MG, Mealey JJ, Neal JH, Olson J, Robertson JT, Barnett GH, Bloomfield S, Albright R, Hochberg FH, Hiesiger E, Green S, Brain Tumor Cooperative Group. Neurosurgery; 2002 Aug 04; 51(2):343-55; discussion 355-7. PubMed ID: 12182772 [Abstract] [Full Text] [Related]
6. BCNU (NSC-409962) and procarbazine (NSC-77213) treatment for malignant brain tumors. Levin VA, Crafts DC, Wilson CB, Schultz MJ, Boldrey EB, Enot KJ, Pischer TL, Seager M, Elashoff RM. Cancer Treat Rep; 1976 Mar 04; 60(3):243-9. PubMed ID: 177210 [Abstract] [Full Text] [Related]
7. Dose escalation of carmustine in surgically implanted polymers in patients with recurrent malignant glioma: a New Approaches to Brain Tumor Therapy CNS Consortium trial. Olivi A, Grossman SA, Tatter S, Barker F, Judy K, Olsen J, Bruce J, Hilt D, Fisher J, Piantadosi S, New Approaches to Brain Tumor Therapy CNS Consortium. J Clin Oncol; 2003 May 01; 21(9):1845-9. PubMed ID: 12721262 [Abstract] [Full Text] [Related]
8. High-dose BCNU followed by autologous hematopoietic stem cell transplantation in supratentorial high-grade malignant gliomas: a retrospective analysis of 114 patients. Durando X, Lemaire JJ, Tortochaux J, Van-Praagh I, Kwiatkowski F, Vincent C, Bailly C, Verrelle P, Irthum B, Chazal J, Bay JO. Bone Marrow Transplant; 2003 Apr 01; 31(7):559-64. PubMed ID: 12692621 [Abstract] [Full Text] [Related]
9. Controlled study with BCNU vs. CCNU as adjuvant chemotherapy following surgery plus radiotherapy for glioblastoma multiforme. Solero CL, Monfardini S, Brambilla C, Vaghi A, Valagussa P, Morello G, Bonadonna G. Cancer Clin Trials; 1979 Apr 01; 2(1):43-8. PubMed ID: 229983 [Abstract] [Full Text] [Related]
10. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma. Tsao MN, Mehta MP, Whelan TJ, Morris DE, Hayman JA, Flickinger JC, Mills M, Rogers CL, Souhami L. Int J Radiat Oncol Biol Phys; 2005 Sep 01; 63(1):47-55. PubMed ID: 16111571 [Abstract] [Full Text] [Related]
11. Survival response of malignant gliomas to radiotherapy with or without BCNU or methyl-CCNU chemotherapy at the University of Kentucky Medical Center. Chin HW, Young AB, Maruyama Y. Cancer Treat Rep; 1981 Sep 01; 65(1-2):45-51. PubMed ID: 7013978 [Abstract] [Full Text] [Related]
12. [Chemotherapy of recurrent supratentorial malignant gliomas (phase II study)]. Afra D, Sipos L, Vitanovics D. Ideggyogy Sz; 2002 Jan 20; 55(1-2):38-44. PubMed ID: 12122942 [Abstract] [Full Text] [Related]
13. Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial. Westphal M, Ram Z, Riddle V, Hilt D, Bortey E, Executive Committee of the Gliadel Study Group. Acta Neurochir (Wien); 2006 Mar 20; 148(3):269-75; discussion 275. PubMed ID: 16482400 [Abstract] [Full Text] [Related]
14. Phase II trial of thalidomide and carmustine for patients with recurrent high-grade gliomas. Fine HA, Wen PY, Maher EA, Viscosi E, Batchelor T, Lakhani N, Figg WD, Purow BW, Borkowf CB. J Clin Oncol; 2003 Jun 15; 21(12):2299-304. PubMed ID: 12805330 [Abstract] [Full Text] [Related]
15. Results of a randomized trial comparing BCNU plus radiotherapy, streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma. Deutsch M, Green SB, Strike TA, Burger PC, Robertson JT, Selker RG, Shapiro WR, Mealey J, Ransohoff J, Paoletti P. Int J Radiat Oncol Biol Phys; 1989 Jun 15; 16(6):1389-96. PubMed ID: 2542193 [Abstract] [Full Text] [Related]
16. Phase III trial of carmustine and cisplatin compared with carmustine alone and standard radiation therapy or accelerated radiation therapy in patients with glioblastoma multiforme: North Central Cancer Treatment Group 93-72-52 and Southwest Oncology Group 9503 Trials. Buckner JC, Ballman KV, Michalak JC, Burton GV, Cascino TL, Schomberg PJ, Hawkins RB, Scheithauer BW, Sandler HM, Marks RS, O'Fallon JR, North Central Cancer Treatment Group 93-72-52, Southwest Oncology Group 9503 Trials. J Clin Oncol; 2006 Aug 20; 24(24):3871-9. PubMed ID: 16921039 [Abstract] [Full Text] [Related]
17. Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme. Levin VA, Uhm JH, Jaeckle KA, Choucair A, Flynn PJ, Yung WKA, Prados MD, Bruner JM, Chang SM, Kyritsis AP, Gleason MJ, Hess KR. Clin Cancer Res; 2000 Oct 20; 6(10):3878-84. PubMed ID: 11051233 [Abstract] [Full Text] [Related]
18. Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma. Weller M, Müller B, Koch R, Bamberg M, Krauseneck P, Neuro-Oncology Working Group of the German Cancer Society. J Clin Oncol; 2003 Sep 01; 21(17):3276-84. PubMed ID: 12947063 [Abstract] [Full Text] [Related]
19. Treatment of grade III and IV astrocytomas with BCNU alone and in combination with VM-26 following surgery and radiation therapy. Sweet DL, Hendler FJ, Hanlon K, Hekmatpanah J, Griem ML, Duda EE, Mulligan B, Wollman RL. Cancer Treat Rep; 1979 Sep 01; 63(11-12):1707-11. PubMed ID: 230893 [Abstract] [Full Text] [Related]
20. Radiotherapy and chemotherapy of malignant brain gliomas. Hildebrand J. Drugs Exp Clin Res; 1986 Sep 01; 12(1-3):167-75. PubMed ID: 3525072 [Abstract] [Full Text] [Related] Page: [Next] [New Search]